Zohran Mamdani, the Democratic front-runner in the mayor’s race, plans if elected to replace the selective program, which became a symbol of segregation in public schools. By Emma G. Fitzsimmons and ...

Have you ever found yourself wrestling with Excel formulas, wishing for a more powerful tool to handle your data? Or maybe you’ve heard the buzz about Python in Excel and wondered if it’s truly the ...

AlphaFold, the revolutionary, Nobel-prizewinning tool for predicting protein structures, has a problem: it’s running low on data. The latest version of the artificial intelligence (AI) model, ...

The Army is set to dramatically expand how many new recruits it can send to basic training this spring, riding the momentum of recent gains toward reversing a recruiting slump it has struggled with in ...

AI is all about data, and the representation of the data matters strongly. But after focusing primarily on 8-bit integers and 32‑bit floating-point numbers, the industry is now looking at new formats.

Many Democrats failed to turn out to vote at the rate they did in 2020 when they ousted Donald Trump, according to an analysis of election data. By Michael C. Bender Voters in liberal strongholds ...

Language processing happens at speeds significantly faster than it takes to speak one word aloud. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

Forbes contributors publish independent expert analyses and insights. I consult on marketing strategy, content creation, and messaging. At first glance, the solution seems deceptively simple— make the ...

With the emergence of AI tools, upscaling low-quality images to high-quality has become easy. You can use the following tools to upscale your images on Windows PC ...

For the past several years, investors have flocked to biotech on the promise of AI to accelerate drug development, reduce costs and enhance predictability. The math was a no-brainer: Shaving just 10% ...

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate ...